Wednesday, October 03, 2018 11:06:34 AM
Biotech PPS is difficult to anticipate, even on great news. In the last couple of weeks, 3 of my stocks had events.
So, let's see my "luck" :))
* GERN got a discontinuation from J&J and dropped like a rock (68% that day I think) in a bottomless pit. It still has not hit the ground yet. A discontinuation is more of a business event, not like an FDA approval.
* ADMP got a *positive* decision on their lower dose version (0.15mg) of Symjepi. The stock *dropped* (about 13% that day I think)
* ATRS gets *positive* decision on Xyo. Well, you know that story.
And still waiting on NWBO's event and a few more.
With ATRS, I'm nearly up 100% thus far. I expect a lot more actually. (And CYRX has been a good stock :)
Anyways, best of luck to you CYRXorbust.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM